MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Interest & Investment Income (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Interest & Investment Income came in at $278000.0 in Q4 2025, down 73.06% YoY from $1.0 million in Q4 2024, and up 72.67% on a QoQ basis from $161000.0 in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Interest & Investment Income (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Interest & Investment Income data on file, last reported at $278000.0 in Q4 2025.

  • Quarterly Interest & Investment Income fell 73.06% year-over-year to $278000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.8 million (down 56.14% YoY) and the FY2025 annual result came in at $1.8 million, down 56.14% from the prior year.
  • Interest & Investment Income climbed to $278000.0 in Q4 2025, from $161000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.2 million in Q3 2024 to a low of $16000.0 in Q1 2022.
  • A 5-year average of $461250.0 and a median of $420000.0 in 2022 frame the typical range for Interest & Investment Income.
  • Annual changes were most pronounced in 2021 — Interest & Investment Income plunged 88.72% — and 2023, when it surged 3306.25%.
  • Tracing MGTX's Interest & Investment Income over 5 years: stood at $24000.0 in 2021, then soared by 1700.0% to $432000.0 in 2022, then gained by 27.08% to $549000.0 in 2023, then soared by 87.98% to $1.0 million in 2024, then sank by 73.06% to $278000.0 in 2025.
  • The last three Interest & Investment Income figures came in at $278000.0 (Q4 2025), $161000.0 (Q3 2025), and $408000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 35.58 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 5.13 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 10.98 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn 706,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 706,000.00
Dec 31, 2025 278,000.00
Sep 30, 2025 161,000.00
Jun 30, 2025 408,000.00
Mar 31, 2025 971,000.00
Dec 31, 2024 1.03 Mn
Sep 30, 2024 1.19 Mn
Jun 30, 2024 827,000.00
Mar 31, 2024 1.10 Mn
Dec 31, 2023 549,000.00
Sep 30, 2023 523,000.00
Jun 30, 2023 655,000.00
Mar 31, 2023 545,000.00
Dec 31, 2022 432,000.00
Sep 30, 2022 288,000.00
Jun 30, 2022 41,000.00
Mar 31, 2022 16,000.00
Dec 31, 2021 24,000.00
Sep 30, 2021 33,000.00
Jun 30, 2021 67,000.00